Syngenta has established different Programs / Facilities in order to adequately cover the Group's long-term funding requirements as well as the expected fluctuations in working capital.
Debt Capital Market programs
- USD 2'500'000'000 Global Commercial Paper Program
- European Medium Term Notes (EMTN) Program
- Base Prospectus dated March 21, 2014 and listed at the Luxembourg Stock Exchange
- Base Prospectus dated April 6, 2018 and listed at the Luxembourg Stock Exchange
- Base Prospectus dated March 16, 2020 and listed at the Luxembourg Stock Exchange
- First Supplement to the Base Prospectus dated September 18, 2020
- Second Supplement to the Base Prospectus dated November 20, 2020
- Final Terms dated April 14, 2020 of the € 500 million 3.375% Eurobond due April 2026
- Final Terms dated April 22, 2020 of the € 100 million tap of the €500 million 3.375% Eurobond due April 2026
- Final Terms dated October 15, 2020 of the € 200 million tap of the €600 million 3.375% Eurobond due April 2026
- Final Terms dated November 25, 2020 of the € 100 million tap of the €800 million 3.375% Eurobond due April 2026
- Base Prospectus dated April 26, 2021, listed at the Luxembourg Stock Exchange
- Base Prospectus dated May 10, 2022, listed at the Luxembourg Stock Exchange
Committed credit facility
Related to the ChemChina takeover, Syngenta amended, extended and increased its syndicated credit facility in May 2017. The syndicated credit facility has an amount of $3.0 billion and expiry date in 2024. Syngenta also entered into another committed, revolving, bilateral credit facility in 2021. This credit facility has an amount of $1.0 billion and expiry date in 2024.
Long-term debt instruments outstanding
| Instrument | Size | Coupon | Maturity | Documentation |
|---|---|---|---|---|
| Swiss Domestic Bond | CHF 265m | 1.250% | Oct 2023 | Standalone |
| Term Loan | CHF 300m | n/a | Feb 2025 | Term Loan Agreement |
| Term Loan | US$ 1,000m | n/a | Apr 2024 | Term Loan Agreement |
| Swiss Domestic Bond | CHF 225m | 0.625% | Aug 2024 | Standalone |
| Swiss Domestic Bond | CHF 250m | 1.625% | Nov 2024 | EMTN |
| Term Loan | US$ 250m | n/a | Apr 2025 | Term Loan Agreement |
| US$ 144A/RegS Notes | US$ 677m | 4.892% | Apr 2025 | 144A/RegS |
| Private Placement Notes | US$ 55m | 5.35% | Dec 2025 | Note Purchase Agreement |
| Eurobond | € 900m | 3.375% | Apr 2026 | EMTN |
| Term Loan | US$ 300m | n/a | Apr 2026 | Term Loan Agreement |
| Swiss Domestic Bond | CHF 140m | 0.700% | Dec 2026 | Standalone |
| Eurobond | € 500m | 1.25% | Sept 2027 | EMTN |
| US$ 144A/RegS Notes | US$ 336m | 5.182% | Apr 2028 | 144A/RegS |
| Swiss Domestic Bond | CHF 150m | 2.125% | Nov 2029 | EMTN |
| Private Placement Notes | US$ 11m | 5.59% | Dec 2035 | Note Purchase Agreement |
| US$ Notes | US$ 20m | 4.375% | Mar 2042 | US Shelf |
| US$ 144A/RegS Notes | US$ 153m | 5.676% | Apr 2048 | 144A/RegS |
Current long-term debt maturity profile
Excluding related party balances (cf. notes to the 2022 financial statements)